Genetic Alterations of Androgen Receptor Gene in Japanese Human Prostate Cancer

In order to determine the significance of androgen receptor (AR) gene mutations for Japanese prostate cancers, we examined the entire coding region, from exon A to H, in 36 primary lesions. Five in stage A, 12 in stage B, six in stage C and 13 in stage D were subjected to PCR-SSCP analysis for genom...

Full description

Saved in:
Bibliographic Details
Published in:Japanese journal of clinical oncology 1997-12, Vol.27 (6), p.389-393
Main Authors: Watanabe, Masatoshi, Ushijima, Toshikazu, Shiraishi, Taizo, Yatani, Ryuichi, Shimazaki, Jun, Kotake, Toshihiko, Sugimura, Takashi, Nagao, Minako
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
androgen receptor gene
CAG repeats
Codon - genetics
Humans
Male
Middle Aged
Mutation
Polymerase Chain Reaction
Polymorphism, Single-Stranded Conformational
prostate cancer
Prostatectomy
Prostatic Neoplasms - genetics
Prostatic Neoplasms - surgery
Receptors, Androgen - genetics
refractory to hormone therapy
Sequence Analysis, DNA
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In order to determine the significance of androgen receptor (AR) gene mutations for Japanese prostate cancers, we examined the entire coding region, from exon A to H, in 36 primary lesions. Five in stage A, 12 in stage B, six in stage C and 13 in stage D were subjected to PCR-SSCP analysis for genomic DNA and nucleotide sequencing. Mutations were detected in five samples (14%). Two in stage D and refractory to anti-androgen treatment showed mis-sense mutations. The other three showed changes in the length of the CAG repeat in exon A, with an expansion or a contraction of one repeat unit. However, no association with changes in AR function was indicated because they had not been refractory to hormone therapy. Since these latter three tumors were associated with microsatellite instability, the changes might have been the result of an impairment of mismatch repair. This study indicates that AR gene mutations play a role, in only a subset of prostate cancer patients, in a treatment-refractory state.
ISSN:0368-2811
1465-3621
DOI:10.1093/jjco/27.6.389